Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2007-11-13
2007-11-13
Campell, Bruce (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C435S320100, C514S04400A
Reexamination Certificate
active
10211502
ABSTRACT:
Disclosed is an immunological or vaccine composition that includes at least one plasmid that contains and expresses in vivo in host canine cells a nucleic acid molecule that encodes an antigen of a canine pathogen, such as rabies G. The plasmid can include more that one nucleic acid molecule such that the plasmid can express more than one antigen. Also disclosed are methods for using and kits employing such compositions.
REFERENCES:
patent: 5494807 (1996-02-01), Paoletti et al.
patent: 5843456 (1998-12-01), Paoletti et al.
patent: 5846946 (1998-12-01), Huebner et al.
patent: 6063385 (2000-05-01), Schultz
patent: 6187759 (2001-02-01), Tarpey et al.
patent: 6228846 (2001-05-01), Audonnet et al.
patent: 6451770 (2002-09-01), Rijsewijk et al.
patent: 6586412 (2003-07-01), Audonnet et al.
patent: WO 95/20660 (1995-08-01), None
patent: WO 97/40163 (1997-10-01), None
patent: WO 97/41236 (1997-11-01), None
Endres et al. Suppression of simian immunodeficiency virus replication by human immunodeficiency virus type 1 trans-dominant negative rev mutants. Journal of Virology, Aug. 1995, vol. 69(8), p. 5164-5166.
Xiang et al. Immune responses to nucleic acid vaccines to rabies virus. Virology, 1995, 209, p. 569-579.
Ertl et al. Plasmid vectors as anti-viral vaccines. DNA Vaccines, A new Era in Vaccinology, 1995, vol. 6, p. 77-87.
Perrin et al. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine, 2000, vol. 18, 479-486.
Gurunathan et al. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol., 2000, vol. 18, 927-974.
Z.Q. Xiang, et al., “Immune Response to Nucleic Acid Vaccines to Rabies Virus”, Virology, vol. 209-2 (1995) pp. 569-579.
Jiang et al., Nucleic Acid Immunization Protects Dogs Against Challenge with Virulent Canine Parvorirus, Vaccine 16(6):601-607, 1998.
Sixt et al., Canine Distemper Virus DNA Vaccination Induces Humoral and Cellular Immunity and Protects Against a Lethal Intracerebral Challenge, Journal of Virology, 72(11):8472-8476, 1998.
Tighe et al., Gene Vaccination: Plasmid DNA is More Than Just a Blueprint. Immunology Today 19(2):89-97, 1998.
Ertl, H.C. et al., “Plasmid Vectors as Anti-Viral Vaccines” DNA Vaccines, A new Era in Vaccinology 1995, vol. 6: 77-87.
Prrin, P., et al., “Immunization of Dogs with a DNA Vaccines Induces Protection Against Rabies Virus” Vaccine 2000, vol. 18: 479-486.
Osorio, J.E., et al. “Immunization of Dogs and Cats with a DNA Vaccine Against Rabies Virus” Vaccine 1999, vol. 17: 1109-1116.
Schultz, J. et al. “Update on antiviral DNA vaccine research (1998-2000).” Intervirology 2000 43:197-217.
Audonnet Jean-Christophe
Bouchardon Annabelle
Riviere Michel
Campell Bruce
Frommer & Lawrence & Haug LLP
Jarecki-Black Judy
Kowalski Thomas J.
Le Emily M.
LandOfFree
Polynucleotide vaccine formula against canine pathologies,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotide vaccine formula against canine pathologies,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide vaccine formula against canine pathologies,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3873108